Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Plan established with FDA for sBLA filing for Erbitux

July 23, 2004

Novel antiinflammatory agents trigger apoptosis in cancer cell lines

July 22, 2004

Eligard six-month product submitted for approval in Canada

July 22, 2004

Yamanouchi reports VEGF inhibitors for angiogenesis-related disorders

July 21, 2004

First phase II monotherapy study of 17-AAG begins

July 21, 2004

Telomerase inhibitor inhibits glioblastoma growth in vivo

July 21, 2004

Tyropeptin A analogues with antitumor activity disclosed in patent

July 20, 2004

TGF-beta inhibitor claimed in Lilly patent

July 20, 2004

Aldara receives approval for superficial basal cell carcinoma

July 20, 2004

CancerVax licenses rights to SAI product candidates targeting EGFR

July 20, 2004

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...